Sign up for free insights newsletter
AE

Aedifica

AEDBR

Need professional-grade analysis? Visit stockanalysis.com

€70.50
-4.99%
End of day
Market Cap

$3.49B

P/E Ratio

14.30

Employees

131

Dividend Yield

5.56%

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-2.331.712.031.59-0.050.86
Calmar-6.382.602.421.84-0.010.73
Sharpe-2.131.261.391.08-0.040.54
Omega0.501.251.271.201.011.10
Martin-10.077.078.124.56-0.022.96
Ulcer6.564.063.294.6635.0212.47

Aedifica (AED) Price Performance

Aedifica (AED) trades on BR in EUR. The company is classified in the Real Estate sector under the REIT - Healthcare Facilities industry. The stock currently trades at EUR70.50, down 4.99% from the previous close.

Over the past year, AED has traded between a low of EUR55.62 and a high of EUR79.25. The stock has gained 21.5% over this period. It is currently 11.0% below its 52-week high.

Aedifica has a market capitalization of $3.49B, with a price-to-earnings ratio of 14.30 and a dividend yield of 5.56%.

About Aedifica

Aedifica NV/SA is a Regulated Real Estate Company under Belgian law specialised in European healthcare real estate, particularly in elderly care. Aedifica has developed a portfolio of approx. 615 sites in Belgium, Germany, the Netherlands, the United Kingdom, Finland, Ireland and Spain, worth approx. 6.2 billion. Aedifica is listed on Euronext Brussels (2006) and Euronext Amsterdam (2019). Since 2020, Aedifica has been part of the BEL 20, Euronext Brussels leading share index. Moreover, since 2023, Aedifica has been part of the BEL ESG, the index tracking companies that perform best on ESG criteria. Aedifica is also included in the EPRA, Stoxx Europe 600 and GPR indices. Aedificas market capitalisation was approx. 3.2 billion as at 18 November 2025. Aedifica NV/SA was incorporated in 2005 in Belgium.

Company Info

Exchange
BR
Currency
EUR
Country
Belgium

Financial Metrics

Revenue (TTM)
$368.94M
EBITDA
$314.35M
Profit Margin
66.25%
EPS (TTM)
5.14
Book Value
77.05

Technical Indicators

52 Week High
€80.05
52 Week Low
€54.30
50 Day MA
€74.57
200 Day MA
€67.05
Beta
0.98

Valuation

Trailing P/E
14.30
Forward P/E
13.51
Price/Sales
9.47
Price/Book
0.93
Enterprise Value
$5.88B